Is eHealth, Inc. overvalued or undervalued?

As of 31 October 2025, the valuation grade for eHealth, Inc. moved from attractive to very attractive, indicating a strong improvement in its perceived value. The company appears to be undervalued, supported by a P/E ratio of 6, a Price to Book Value of 0.20, and an EV to EBITDA of 0.40. In comparison, its peer Abacus Life, Inc. has a significantly higher P/E ratio of 164.30, highlighting the relative undervaluation of eHealth.
With a PEG ratio of 0.02, eHealth, Inc. shows potential for growth at a low price, further reinforcing its attractive valuation. Although return data is not available for a direct comparison with the S&P 500, the substantial difference in valuation ratios suggests that eHealth may offer a compelling investment opportunity relative to its peers.